Nanovery is developing nanorobots to diagnose the world's deadliest diseases.

Learn More Learn More

£133 bn

the global market size of companion diagnostics for cancer alone

70%

the predicted increase of incidence of cancer over the next 20 years

9 600 000

the number of deaths caused by cancer in 2018 according to World Health Organization

We are collaborating with renowned academic and clinical partners, giving us access to thousands of patient samples and a proprietary dataset.


Detecting cancer from a blood sample is still too slow

Recent advances have enabled early detection of cancers with just a blood sample, but this can still take 2 weeks. Cancer diagnoses using scans and tissue biopsy are slow, expensive and risky for patients. With the advancement of liquid biopsy, patients can be screened or diagnosed with just a blood sample, but this technique is still slow and expensive as it relies on PCR and sequencing.

We are creating a point-of-care solution that is 10× cheaper and 100× faster

Our nanorobots are added to blood samples. When they capture a cancer biomarker they light up, allowing point-of-care testing. As there is no need for high capital expenditure, our nanorobots are 10 times cheaper. The whole process is also more than 100 times faster – a matter of one or two hours rather than weeks – as there is no need for complex lab protocols which require bioinformaticians to analyse the data.

...

We are creating a point-of-care solution that is 10× cheaper and 100× faster

Our nanorobots are added to blood samples. When they capture a cancer biomarker they light up, allowing point-of-care testing. As there is no need for high capital expenditure, our nanorobots are 10 times cheaper. The whole process is also more than 100 times faster – a matter of one or two hours rather than weeks – as there is no need for complex lab protocols which require bioinformaticians to analyse the data.

...

Detecting cancer from a blood sample is still too slow

Recent advances have enabled early detection of cancers with just a blood sample, but this can still take 2 weeks. Cancer diagnoses using scans and tissue biopsy are slow, expensive and risky for patients. With the advancement of liquid biopsy, patients can be screened or diagnosed with just a blood sample, but this technique is still slow and expensive as it relies on PCR and sequencing.

Traditional research Nanorobot
Method NGS/qPCR DNA computing and nanotech
Price $5.000/test $500/test
Time 1 - 2 weeks 1 - 2 hours
Opportunities The ability to detect new cancer mutations thanks to Nanovery AI

How does nanorobot work?

1.

1.

Cancer DNA is in blood.

2.

2.

The nanorobot is inserted into the blood sample.

3.

3.

Nanorobots distinguishes specific cancer mutation.

4.

4.

After 1 - 2 hours it lights up if it found a mutation.

5.

5.

Thanks to AI, Nanovery designs new nanorobots for new cancer mutations.

Contact Us!

Address
Newcastle upon tyne UK
Support
info@nanovery.co.uk